Recro Pharma, Inc.
(NASDAQ : REPH)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 1.02%304.570.0%$5126.95m
BNTXBioNTech SE 2.01%340.180.0%$1563.49m
NVAXNovavax, Inc. -0.59%161.0278.2%$852.50m
AMGNAmgen, Inc. 0.71%202.601.4%$597.46m
GILDGilead Sciences, Inc. -0.20%69.531.0%$508.76m
VRTXVertex Pharmaceuticals, Inc. 0.09%204.641.9%$479.45m
REGNRegeneron Pharmaceuticals, Inc. -1.12%626.902.7%$468.73m
LGVNLongeveron Inc. 20.83%21.750.0%$433.76m
ILMNIllumina, Inc. -3.76%344.053.3%$313.04m
SNSSSunesis Pharmaceuticals, Inc. -2.80%4.160.7%$290.80m
BIIBBiogen, Inc. -2.15%223.601.8%$272.98m
OCGNOcugen, Inc. -8.72%5.760.0%$193.29m
INCYIncyte Corp. -1.12%65.892.4%$154.49m
EXASEXACT Sciences Corp. -4.54%76.9118.0%$148.96m
SGENSeagen Inc. -5.79%149.495.8%$142.63m

Company Profile

Recro Pharma, Inc. is a pharmaceutical company, which engages in the contract development and manufacturing organization (CDMO). The firm offers integrated solutions for formulation, analytical services, regulatory support, manufacturing and packaging of both commercial and development stage oral solid dose drug products. The company was founded by Geraldine A. Henwood and Thomas F. Henwood on November 15, 2007 and is headquartered in Exton, PA.